45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published: assessment threshold met
●Gross / standard charges: assessment threshold met
●Discounted cash price: assessment threshold met
●Payer-specific negotiated rates: assessment threshold met
○Min / max negotiated charges: below assessment threshold
●Free, public, no login required: assessment threshold met
Procedures listed
4,392
Insurances with rates
26
CPT / HCPCS codes
2,906
Most expensive procedures (gross)
J0224
$402,025
LUMASIRAN 94.5 MG/0.5 ML SUBCUTANEOUS SOLUTION
Gross
$402,025
J0224
$402,025
LUMASIRAN 94.5 MG/0.5 ML SUBCUTANEOUS SOLUTION
Gross
$402,025
A9607
$392,816
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN
Gross
$392,816
A9607
$392,816
LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN
Gross
$392,816
A9606
$239,945
RADIUM RA 223 DICHLOR 1,100 KBQ/ML (30 MICROCURIE/ML) INTRAVENOUS SOLN
Gross
$239,945
A9606
$239,945
RADIUM RA 223 DICHLOR 1,100 KBQ/ML (30 MICROCURIE/ML) INTRAVENOUS SOLN
Gross
$239,945
Q9982
$227,832
FLUTEMETAMOL F-18 5 MCI (185 MBQ) INTRAVENOUS SOLUTION
Gross
$227,832
Q9982
$227,832
FLUTEMETAMOL F-18 5 MCI (185 MBQ) INTRAVENOUS SOLUTION
Gross
$227,832
J2350
$76,604
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$76,604
J2350
$76,604
OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION
Gross
$76,604
J3101
$50,836
TENECTEPLASE 50 MG INTRAVENOUS SOLUTION
Gross
$50,836
J3101
$50,836
TENECTEPLASE 50 MG INTRAVENOUS SOLUTION
Gross
$50,836
A9595
$45,072
PIFLUFOLASTAT F 18 296 MBQ TO 370 MBQ (8 MCI TO 10 MCI) IV SYRINGE
Gross
$45,072
A9595
$45,072
PIFLUFOLASTAT F 18 296 MBQ TO 370 MBQ (8 MCI TO 10 MCI) IV SYRINGE
Gross
$45,072
J1950
$43,672
LEUPROLIDE 11.25 MG (PEDIATRIC 3 MONTH) INTRAMUSCULAR SYRINGE KIT
Gross
$43,672
J1950
$43,672
LEUPROLIDE 11.25 MG (PEDIATRIC 3 MONTH) INTRAMUSCULAR SYRINGE KIT
Gross
$43,672
A9588
$42,667
FLUCICLOVINE F18 10 MCI (370 MBQ) INTRAVENOUS SOLUTION
Gross
$42,667
A9588
$42,667
FLUCICLOVINE F18 10 MCI (370 MBQ) INTRAVENOUS SOLUTION
Gross
$42,667
A9596
$42,460
KIT FOR PREPARATION OF GA-68-GOZETOTIDE 25 MCG INTRAVENOUS SOLUTION
Gross
$42,460
A9596
$42,460
KIT FOR PREPARATION OF GA-68-GOZETOTIDE 25 MCG INTRAVENOUS SOLUTION
Gross
$42,460
J9022
$42,217
ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION
Gross
$42,217
J9022
$42,217
ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION
Gross
$42,217
J2783
$36,651
RASBURICASE 7.5 MG INTRAVENOUS SOLUTION
Gross
$36,651
J2783
$36,651
RASBURICASE 7.5 MG INTRAVENOUS SOLUTION
Gross
$36,651
J3380
$35,360
VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION
Gross
$35,360
J3380
$35,360
VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION
Gross
$35,360
J9228
$34,130
IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$34,130
J9228
$34,130
IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION
Gross
$34,130
J2323
$33,494
NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION
Gross
$33,494
J2323
$33,494
NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION
Gross
$33,494
A9592
$33,226
COPPER CU-64 DOTATATE 148 MBQ/4 ML (4 MCI/4 ML) INTRAVENOUS SOLUTION
Gross
$33,226
A9592
$33,226
COPPER CU-64 DOTATATE 148 MBQ/4 ML (4 MCI/4 ML) INTRAVENOUS SOLUTION
Gross
$33,226
A9572
$33,139
INDIUM 111-PENTETREOTIDE 3 MCI/ML-10 MCG INTRAVENOUS KIT
Gross
$33,139
A9572
$33,139
INDIUM 111-PENTETREOTIDE 3 MCI/ML-10 MCG INTRAVENOUS KIT
Gross
$33,139
J1162
$31,687
DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION
Gross
$31,687
J1162
$31,687
DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION
Gross
$31,687
HC COM CON OR PROCEDURE LEVEL 4 1ST HR
$20,382
HC COM CON OR PROCEDURE LEVEL 4 1ST HR
Gross
$31,357
A9570
$30,863
INDIUM IN-111 OXYQUINOLINE 1 MCI/ML (37 MBQ/ML)(1 ML) INTRAVENOUS SOLN
Gross
$30,863
A9571
$30,863
INDIUM IN-111 OXYQUINOLINE 1 MCI/ML (37 MBQ/ML) PLATELET (UW 174240)
Gross
$30,863
A9570
$30,863
INDIUM IN-111 OXYQUINOLINE 1 MCI/ML (37 MBQ/ML)(1 ML) INTRAVENOUS SOLN
Gross
$30,863
A9571
$30,863
INDIUM IN-111 OXYQUINOLINE 1 MCI/ML (37 MBQ/ML) PLATELET (UW 174240)
Gross
$30,863
A9557
$30,719
KIT FOR PREPARATION OF TC-99M-BICISATE 0.9 MG INTRAVENOUS SOLUTION
Gross
$30,719
A9557
$30,719
KIT FOR PREPARATION OF TC-99M-BICISATE 0.9 MG INTRAVENOUS SOLUTION
Gross
$30,719
J9299
$29,940
NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION
Gross
$29,940
J9299
$29,940
NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION
Gross
$29,940
J9308
$29,136
RAMUCIRUMAB 10 MG/ML INTRAVENOUS SOLUTION
Gross
$29,136
J9308
$29,136
RAMUCIRUMAB 10 MG/ML INTRAVENOUS SOLUTION
Gross
$29,136
J2353
$27,108
OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE
Gross
$27,108
J2353
$27,108
OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE
Gross
$27,108
J1300
$26,614
ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION
Gross
$26,614
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0224 | LUMASIRAN 94.5 MG/0.5 ML SUBCUTANEOUS SOLUTION | $402,025 | $402,025 | — | — | 22 |
| J0224 | LUMASIRAN 94.5 MG/0.5 ML SUBCUTANEOUS SOLUTION | $402,025 | $402,025 | — | — | 22 |
| A9607 | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN | $392,816 | $392,816 | — | — | 22 |
| A9607 | LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN 27 MCI/ML (1,000 MBQ/ML) IV SOLN | $392,816 | $392,816 | — | — | 22 |
| A9606 | RADIUM RA 223 DICHLOR 1,100 KBQ/ML (30 MICROCURIE/ML) INTRAVENOUS SOLN | $239,945 | $239,945 | — | — | 22 |
| A9606 | RADIUM RA 223 DICHLOR 1,100 KBQ/ML (30 MICROCURIE/ML) INTRAVENOUS SOLN | $239,945 | $239,945 | — | — | 22 |
| Q9982 | FLUTEMETAMOL F-18 5 MCI (185 MBQ) INTRAVENOUS SOLUTION | $227,832 | $227,832 | — | — | 22 |
| Q9982 | FLUTEMETAMOL F-18 5 MCI (185 MBQ) INTRAVENOUS SOLUTION | $227,832 | $227,832 | — | — | 22 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $76,604 | $76,604 | — | — | 22 |
| J2350 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION | $76,604 | $76,604 | — | — | 22 |
| J3101 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $50,836 | $50,836 | — | — | 22 |
| J3101 | TENECTEPLASE 50 MG INTRAVENOUS SOLUTION | $50,836 | $50,836 | — | — | 22 |
| A9595 | PIFLUFOLASTAT F 18 296 MBQ TO 370 MBQ (8 MCI TO 10 MCI) IV SYRINGE | $45,072 | $45,072 | — | — | 22 |
| A9595 | PIFLUFOLASTAT F 18 296 MBQ TO 370 MBQ (8 MCI TO 10 MCI) IV SYRINGE | $45,072 | $45,072 | — | — | 22 |
| J1950 | LEUPROLIDE 11.25 MG (PEDIATRIC 3 MONTH) INTRAMUSCULAR SYRINGE KIT | $43,672 | $43,672 | — | — | 22 |
| J1950 | LEUPROLIDE 11.25 MG (PEDIATRIC 3 MONTH) INTRAMUSCULAR SYRINGE KIT | $43,672 | $43,672 | — | — | 22 |
| A9588 | FLUCICLOVINE F18 10 MCI (370 MBQ) INTRAVENOUS SOLUTION | $42,667 | $42,667 | — | — | 22 |
| A9588 | FLUCICLOVINE F18 10 MCI (370 MBQ) INTRAVENOUS SOLUTION | $42,667 | $42,667 | — | — | 22 |
| A9596 | KIT FOR PREPARATION OF GA-68-GOZETOTIDE 25 MCG INTRAVENOUS SOLUTION | $42,460 | $42,460 | — | — | 22 |
| A9596 | KIT FOR PREPARATION OF GA-68-GOZETOTIDE 25 MCG INTRAVENOUS SOLUTION | $42,460 | $42,460 | — | — | 22 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $42,217 | $42,217 | — | — | 22 |
| J9022 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION | $42,217 | $42,217 | — | — | 22 |
| J2783 | RASBURICASE 7.5 MG INTRAVENOUS SOLUTION | $36,651 | $36,651 | — | — | 22 |
| J2783 | RASBURICASE 7.5 MG INTRAVENOUS SOLUTION | $36,651 | $36,651 | — | — | 22 |
| J3380 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $35,360 | $35,360 | — | — | 22 |
| J3380 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION | $35,360 | $35,360 | — | — | 22 |
| J9228 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION | $34,130 | $34,130 | — | — | 22 |
| J9228 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION | $34,130 | $34,130 | — | — | 22 |
| J2323 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION | $33,494 | $33,494 | — | — | 22 |
| J2323 | NATALIZUMAB 300 MG/15 ML INTRAVENOUS SOLUTION | $33,494 | $33,494 | — | — | 22 |
| A9592 | COPPER CU-64 DOTATATE 148 MBQ/4 ML (4 MCI/4 ML) INTRAVENOUS SOLUTION | $33,226 | $33,226 | — | — | 22 |
| A9592 | COPPER CU-64 DOTATATE 148 MBQ/4 ML (4 MCI/4 ML) INTRAVENOUS SOLUTION | $33,226 | $33,226 | — | — | 22 |
| A9572 | INDIUM 111-PENTETREOTIDE 3 MCI/ML-10 MCG INTRAVENOUS KIT | $33,139 | $33,139 | — | — | 22 |
| A9572 | INDIUM 111-PENTETREOTIDE 3 MCI/ML-10 MCG INTRAVENOUS KIT | $33,139 | $33,139 | — | — | 22 |
| J1162 | DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION | $31,687 | $31,687 | — | — | 22 |
| J1162 | DIGOXIN IMMUNE FAB 40 MG INTRAVENOUS SOLUTION | $31,687 | $31,687 | — | — | 22 |
| HC COM CON OR PROCEDURE LEVEL 4 1ST HR | HC COM CON OR PROCEDURE LEVEL 4 1ST HR | $31,357 | $20,382 | — | — | 22 |
| A9570 | INDIUM IN-111 OXYQUINOLINE 1 MCI/ML (37 MBQ/ML)(1 ML) INTRAVENOUS SOLN | $30,863 | $30,863 | — | — | 22 |
| A9571 | INDIUM IN-111 OXYQUINOLINE 1 MCI/ML (37 MBQ/ML) PLATELET (UW 174240) | $30,863 | $30,863 | — | — | 22 |
| A9570 | INDIUM IN-111 OXYQUINOLINE 1 MCI/ML (37 MBQ/ML)(1 ML) INTRAVENOUS SOLN | $30,863 | $30,863 | — | — | 22 |
| A9571 | INDIUM IN-111 OXYQUINOLINE 1 MCI/ML (37 MBQ/ML) PLATELET (UW 174240) | $30,863 | $30,863 | — | — | 22 |
| A9557 | KIT FOR PREPARATION OF TC-99M-BICISATE 0.9 MG INTRAVENOUS SOLUTION | $30,719 | $30,719 | — | — | 22 |
| A9557 | KIT FOR PREPARATION OF TC-99M-BICISATE 0.9 MG INTRAVENOUS SOLUTION | $30,719 | $30,719 | — | — | 22 |
| J9299 | NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION | $29,940 | $29,940 | — | — | 22 |
| J9299 | NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION | $29,940 | $29,940 | — | — | 22 |
| J9308 | RAMUCIRUMAB 10 MG/ML INTRAVENOUS SOLUTION | $29,136 | $29,136 | — | — | 22 |
| J9308 | RAMUCIRUMAB 10 MG/ML INTRAVENOUS SOLUTION | $29,136 | $29,136 | — | — | 22 |
| J2353 | OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE | $27,108 | $27,108 | — | — | 22 |
| J2353 | OCTREOTIDE,MICROSPHERES ER 30 MG INTRAMUSCULAR SUSP, EXTENDED RELEASE | $27,108 | $27,108 | — | — | 22 |
| J1300 | ECULIZUMAB 300 MG/30 ML INTRAVENOUS SOLUTION | $26,614 | $26,614 | — | — | 22 |
Showing top 50 of 4,392 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.